Edwards Lifesciences Corp: (NYSE: EW)

$64.30

-1.70 (-2.58%)

Volume 2,086,729

May 22 04:00 PM ET

Zacks Rank: 4-Sell

 
 
 
#4
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 64.07 - 66.95
52wk Low - High 62.34 - 110.79
Previous Close 66.00
Avg. Volume 1,798,814
Industry MED PRODUCTS
Market Cap 7.36 B
Div - Yield 0.00 - 0.00
Beta 0.43
PE (Forward) 21.08
Current Year Est. 3.05
Quarterly Earnings ESP 0.00%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Rank Change Trend4

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Neutral

Zacks Industry Rank

184 out of 265

Equity Research Report

Updated as of 04/24/2013

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

PE (Forward) 21.08
PEG Ratio 1.22
Current Year Est. 3.05
Current Quarter Estimate 0.77
Most Accurate Estimate 0.77
Earnings ESP 0.00%
Next Earnings Report Date 07-23-2013
EPS Last Year 2.87
Expected Earnings Growth 17.28%

Company Description

Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

EW Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate 0.77 0.70 3.05 3.68
Number of Estimates 13 12 14 13
Low Estimate 0.75 0.66 3.00 3.46
High Estimate 0.78 0.73 3.08 NA
Year Ago EPS 0.67 0.58 2.69 3.05
EPS Growth 14.35% 20.83% 13.41% 20.75%

Average Earnings Estimates for EW

EPS Growth for EW

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
EDWARDS LIFESCI EW 64.30
ATRICURE INC ATRC 9.14
CONCEPTUS INC CPTS 30.94
INVIVO THERAPT NVIV 2.90
TRANS1 INC TSON 1.80
ABAXIS INC ABAX 43.51
ADVAXIS INC ADXS 0.04
BAXTER INTL BAX 72.30
BIO-RAD LABS -A BIO 115.39
BIOLIFE SOL INC BLFS 0.37

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Financials

EPS TTM 2.87
Sales 1,900
Net Income 373
Price/Earnings 22.40
Price/Book 4.62
Price/Cash Flow 19.77
Price/Sales 3.80

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.